Arcus Biosciences, Inc.
RCUSBiotechnology
$18.61+1.20%As of Oct 29vs prior close
- Market cap
- $2.4B
- P/E (TTM)
- –
- From 52W high
- −41.05%
- EPS (LTM)
- -$3.89
- Revenue (LTM)
- $117M
- Net margin
- -393.16%
- Dividend yield
- 0.00%
Nomior Score
26
Fragile PremiumSpeculativeBottom 11% of the scored universe
Growth32
Quality28
Value33
Momentum65
Resilience25
Growth
+90.69%revenue a year over 8 fiscal years
YE17 $1.4MLTM $117M
Connections
Revenue to profitQ2 YE26
The operating loss was 234% of revenue, wider by 229 pts on a year.
Who owns it
2funds